Acadia Healthcare(ACHC) - 2025 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - The company reported Q4 2025 revenue of $821.5 million, a 6.1% increase year-over-year. Full-year revenue for 2025 was $3.31 billion, reflecting a 5% increase over the prior year [13][14] - Adjusted EBITDA for Q4 was $99.8 million, with full-year adjusted EBITDA at $608.9 million, near the upper end of guidance [13][14] - Same-facility revenue grew 4.4% year-over-year in Q4, driven by a 1.3% increase in revenue per patient day and a 3.1% increase in patient days [14] Business Line Data and Key Metrics Changes - The company added 181 beds in Q4 2025, totaling 1,089 beds added for the full year, exceeding guidance [15][16] - Startup losses related to new facilities were $12.8 million in Q4, compared to $11.2 million in Q4 2024 [14] - The company expects to add between 400 and 600 new beds in 2026, primarily through new facilities nearing completion [16] Market Data and Key Metrics Changes - The company has expanded its footprint to over 12,500 beds, serving 84,000 patients per day [22] - The New York Medicaid program changes are expected to impact same-facility growth by approximately 350 basis points [18][19] Company Strategy and Development Direction - The focus is on operational excellence and execution, with a commitment to quality management and accountability [5][6] - The company is evaluating service lines comprehensively to ensure alignment with long-term value creation [10] - Joint ventures with leading health systems are being pursued to expand presence and better serve local communities [7][8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong demand for behavioral health services and the potential to unlock significant EBITDA and free cash flow from existing facilities [9][12] - The company anticipates a challenging environment but remains focused on delivering quality care and improving operational performance [22] - Management expects full-year 2026 revenue to be between $3.37 billion and $3.45 billion, with adjusted EBITDA of $575 million to $610 million [17] Other Important Information - The company is committed to maintaining strong relationships with partners and aligning staffing with patient needs [6][10] - Regulatory matters are being addressed, with a focus on recruitment and retention of qualified staff [11] Q&A Session Summary Question: Status of the value creation review - Management confirmed that the value creation review is ongoing and focused on immediate progress while also considering long-term value [26][27] Question: Growth algorithm in the current environment - Management believes the growth algorithm remains unchanged, with strong demand expected to continue [29] Question: Timeline for realizing embedded earnings from development activity - Management indicated that the realization of the $200 million incremental EBITDA opportunity is expected within five years [34][35] Question: Addressing average length of stay pressures from managed Medicaid - Management acknowledged the challenges but emphasized stable length of stay metrics and advocacy for patient needs [41][43] Question: Plans to rebuild trust with referral sources - Management highlighted the importance of consistent high-quality care and effective communication with referral sources [52][54] Question: Long-term CapEx strategy - Management indicated a significant reduction in CapEx for 2026, focusing on existing facilities and potential M&A opportunities [60][63] Question: Impact of California's new staffing requirements - Management expects a $4 million EBITDA impact from California's new staffing guidelines, which is included in guidance [79][80] Question: Volume growth expectations excluding specific headwinds - Management anticipates underlying core growth in the 1%-2% range, with additional contributions from ramping facilities [114]